Author: Michael Walter Cardiovascular Business News The FDA has issued an emergency use authorization (EUA) for Abiomed’s left-sided Impella heart pumps, approving their use as a tool to provide unloading therapy for COVID-19 patients undergoing extracorporeal membrane oxygenation (ECMO). “The early clinical evidence continues to accrue in favor of including left ventricular unloading in many patients […]
Read MoreAuthor: Michael Walter Cardiovascular Business News Obesity is associated with a greater risk of a severe COVID-19 infection, according to a new analysis published in Circulation. It may not necessarily be an independent risk factor, the authors noted, but it appears to be a consistent indicator that serious complications may arise. “We suggest obesity or excess […]
Read MoreAuthors: Prabhakar, Hemanshu MD, PhD; Mahajan, Charu MD, DM; Kapoor, Indu MD Anesthesia & Analgesia: August 2020 – Volume 131 – Issue 2 – p e91-e92 To the Editor The pandemic coronavirus disease 19 (COVID-19) is rapidly spreading across the world, and the numbers of affected and those deceased are increasing at an alarming rate. […]
Read MoreAuthors: Wald, Samuel H. MD, MBA; Arthofer, Rudolph RN, MHA; Semple, Amy K. RN; Bhorik, Avi MHA; Lu, Amy C. MD, MPH Anesthesia & Analgesia: August 2020 – Volume 131 – Issue 2 – p e94-e96 To the Editor Both aerosol and droplet precautions have been recommended for the care of patients with suspected or […]
Read MoreAuthor:Patricia Kritek, MD reviewing Ferreyro BL et al. JAMA 2020 Jun 4 NEJM Journal Watch A meta-analysis showed lower mortality with noninvasive ventilation compared with standard oxygen therapy. Comparisons of effectiveness among noninvasive ventilation (NIV), high-flow nasal cannula (HFNC), and standard oxygen therapy have yielded conflicting results in patients with respiratory failure who do not require immediate endotracheal intubation. […]
Read More